Myostatin: a modulator of skeletal-muscle stem cells
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Myostatin, or GDF-8 (growth and differentiation factor-8), was first identified through sequence identity with members of the BMP (bone morphogenetic protein)/TGF-β (transforming growth factor-β) superfamily. The skeletal-muscle-specific expression pattern of myostatin suggested a role in muscle development. Mice with a targeted deletion of the myostatin gene exhibit a hypermuscular phenotype. In addition, inactivating mutations in the myostatin gene have been identified in ‘double muscled’ cattle breeds, such as the Belgian Blue and Piedmontese, as well as in a hypermuscular child. These findings define myostatin as a negative regulator of skeletal-muscle development. Myostatin binds with high affinity to the receptor serine threonine kinase ActRIIB (activin type IIB receptor), which initiates signalling through a smad2/3-dependent pathway. In an effort to validate myostatin as a therapeutic target in a post-embryonic setting, a neutralizing antibody was developed by screening for inhibition of myostatin binding to ActRIIB. Administration of this antimyostatin antibody to adult mice resulted in a significant increase in both muscle mass and functional strength. Importantly, similar results were obtained in a murine model of muscular dystrophy, the mdx mouse. Unlike the myostatin-deficient animals, which exhibit both muscle hypertrophy and hyperplasia, the antibody-treated mice demonstrate increased musculature through a hypertrophic mechanism. These results validate myostatin inhibition as a therapeutic approach to muscle wasting diseases such as muscular dystrophy, sarcopenic frailty of the elderly and amylotrophic lateral sclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Double muscling in cattle due to mutations in the myostatin gene
McPherron, A. C., & Lee, S.-J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12457 · Cited by 2,039
Regulation of myostatin activity and muscle growth
Lee, S.-J., & McPherron, A. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151270098 · Cited by 1,616
A deletion in the bovine myostatin gene causes the double–muscled phenotype in cattle
Grobet, L., Royo Martin, L. J., Poncelet, D., Pirottin, D., Brouwers, B., Riquet, J., Schoeberlein, A., Dunner, S., Ménissier, F., Massabanda, J., et al. (1997) · Nature Genetics · doi:10.1038/ng0997-71 · Cited by 1,556
Myostatin Mutation Associated with Gross Muscle Hypertrophy in a Child
Schuelke, M., Wagner, K. R., Stolz, L. E., Hübner, C., Riebel, T., Kömen, W., Braun, T., Tobin, J. F., & Lee, S.-J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040933 · Cited by 1,399
Mutations in myostatin ( GDF8 ) in Double-Muscled Belgian Blue and Piedmontese Cattle
Kambadur, R., Sharma, M., Smith, T. P. L., & Bass, J. J. (1997) · Genome Research · doi:10.1101/gr.7.9.910 · Cited by 1,204
Myostatin, a Negative Regulator of Muscle Growth, Functions by Inhibiting Myoblast Proliferation
Thomas, M., Langley, B., Berry, C., Sharma, M., Kirk, S., Bass, J., & Kambadur, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004356200 · Cited by 1,014
Functional improvement of dystrophic muscle by myostatin blockade
Bogdanovich, S., Krag, T. O. B., Barton, E. R., Morris, L. D., Whittemore, L.-A., Ahima, R. S., & Khurana, T. S. (2002) · Nature · doi:10.1038/nature01154 · Cited by 831
Suppression of body fat accumulation in myostatin-deficient mice
McPherron, A. C., & Lee, S.-J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213562 · Cited by 505
Zhu, X., Topouzis, S., Liang, L.-F., & Stotish, R. L. (2004) · Cytokine · doi:10.1016/j.cyto.2004.03.007 · Cited by 230
Research works printed but not linked: 28
- Wagner, 2005, Proc. Natl. Acad. Sci. U.S.A., 102, 2519, 10.1073/pnas.0408729102 · DOI · Paper page
- Grobet, 1998, Mamm. Genome, 9, 210, 10.1007/s003359900727 · DOI · Paper page
- Zhiliang, 2004, Sci. China C Life Sci., 47, 25, 10.1360/02yc0201 · DOI
- Jiang, 2002, Anim. Biotechnol., 13, 173, 10.1081/ABIO-120005778 · DOI
- Berry, 2002, Am. J. Physiol. Cell Physiol., 283, C135, 10.1152/ajpcell.00458.2001 · DOI
- Nishi, 2002, Biochem. Biophys. Res. Commun., 293, 247, 10.1016/S0006-291X(02)00209-7 · DOI
- Wegner, 2000, J. Anim. Sci., 78, 1485, 10.2527/2000.7861485x · DOI · Paper page
- Whittemore, 2003, Biochem. Biophys. Res. Commun., 300, 965, 10.1016/S0006-291X(02)02953-4 · DOI · Paper page
- Grobet, 2003, Genesis, 35, 227, 10.1002/gene.10188 · DOI · Paper page
- Thies, 2001, Growth Factors, 18, 251, 10.3109/08977190109029114 · DOI · Paper page
- Wolfman, 2003, Proc. Natl. Acad. Sci. U.S.A., 100, 15842, 10.1073/pnas.2534946100 · DOI · Paper page
- Hill, 2002, J. Biol. Chem., 277, 40735, 10.1074/jbc.M206379200 · DOI · Paper page
- Hill, 2003, Mol. Endocrinol., 17, 1144, 10.1210/me.2002-0366 · DOI · Paper page
- Scott, 1999, Dev. Biol., 213, 283, 10.1006/dbio.1999.9383 · DOI · Paper page
- Rebbapragada, 2003, Mol. Cell. Biol., 23, 7230, 10.1128/MCB.23.20.7230-7242.2003 · DOI · Paper page
- Philip, 2005, Cell. Signalling, 17, 365, 10.1016/j.cellsig.2004.08.003 · DOI · Paper page
- Rios, 2001, Biochem. Biophys. Res. Commun., 280, 561, 10.1006/bbrc.2000.4159 · DOI
- Rios, 2004, Endocrinology, 145, 2795, 10.1210/en.2003-1166 · DOI · Paper page
- Taylor, 2001, Am. J. Physiol. Endocrinol. Metab., 280, E221, 10.1152/ajpendo.2001.280.2.E221 · DOI · Paper page
- Joulia, 2003, Exp. Cell Res., 286, 263, 10.1016/S0014-4827(03)00074-0 · DOI · Paper page
- Langley, 2002, J. Biol. Chem., 277, 49831, 10.1074/jbc.M204291200 · DOI · Paper page
- Wagner, 2002, Ann. Neurol., 52, 832, 10.1002/ana.10385 · DOI · Paper page
- Pirottin, 2005, Proc. Natl. Acad. Sci. U.S.A., 102, 6413, 10.1073/pnas.0502426102 · DOI
- Bogdanovich, 2005, FASEB J., 19, 543, 10.1096/fj.04-2796com · DOI · Paper page
- Patel, 2005, Neuromuscular Disord, 15, 117, 10.1016/j.nmd.2004.10.018 · DOI · Paper page
- Li, 2005, Am. J. Pathol., 166, 491, 10.1016/S0002-9440(10)62271-7 · DOI
- Zimmers, 2002, Science, 296, 1486, 10.1126/science.1069525 · DOI · Paper page
- Reisz-Porszasz, 2003, Am. J. Physiol. Endocrinol. Metab., 285, E876, 10.1152/ajpendo.00107.2003 · DOI · Paper page
Cited by
Sarcopenia: etiology, clinical consequences, intervention, and assessment
Lang, T., Streeper, T., Cawthon, P., Baldwin, K., Taaffe, D. R., & Harris, T. B. (2010) · Osteoporosis International · doi:10.1007/s00198-009-1059-y · Cited by 777
Transforming growth factor-β and myostatin signaling in skeletal muscle
Kollias, H. D., & McDermott, J. C. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01091.2007 · Cited by 307
Molecular Mechanisms of Glucocorticoid-Induced Insulin Resistance
Beaupere, C., Liboz, A., Fève, B., Blondeau, B., & Guillemain, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020623 · Cited by 271
Cellular Markers of Muscle Atrophy in Chronic Obstructive Pulmonary Disease
Plant, P. J., Brooks, D., Faughnan, M., Bayley, T., Bain, J., Singer, L., Correa, J., Pearce, D., Binnie, M., & Batt, J. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0382oc · Cited by 190
Everything you wanted to know about small RNA but were afraid to ask
Boyd, S. D. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.32 · Cited by 108
Metadata
- Authors
- Walsh, F. S., & Celeste, A. J.
- Venue
- Biochemical Society Transactions
- Publisher
- Portland Press Ltd.
- Published
- 2005-10-26
- Volume
- 33
- Issue
- 6
- Pages
- 1513-1517
- ISSN
- 0300-5127 (ISSN-L)
- 1470-8752
- OpenAlex
- W2126809879
- Cited by
- 77
- References
- 10
- FWCI
- 1.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.